Back
GILD logo

Gilead Sciences, Inc. (GILD)

Biotechnology
GILD · NASDAQ NMS - GLOBAL MARKET · USD
New to investing? How to read this page →
$146.12
+1.87%

Weekly undervalued picks (like GILD)

Price · 1 year
Loading live analysis…
Loading analysis…

Intrinsic Investor is for research and education only. Not financial advice.

Key metrics

EPS
$6.78
ROE
43.4%
Gross margin
79.4%
Debt/Equity
0.95x
Revenue growth
4.4%

Gilead Sciences, Inc. — company intelligence

Earnings surprises

Q2 2026$-6.75 vs $-7.38 est+8.5%
Q1 2026$2.03 vs $1.95 est+4.0%
Q4 2025$1.86 vs $1.85 est+0.7%
Q3 2025$2.47 vs $2.17 est+13.7%

Analyst consensus · 37 analysts

30 Buy7 Hold0 Sell
Updated Aug 12, 2026

Insider activity · 90 days

0 buys20 sellsnet -67,349 shares
Cain Wettan Keeley Mother 6,002 · Aug 10, 2026
Cain Wettan Keeley MSell 2,908 · Aug 10, 2026
O'Day Daniel PatrickSell 600 · Aug 3, 2026

AI Valuation Narrative

Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.

Weekly undervalued picks (like GILD)

Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.

Free. No spam. We only email once per week.

Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.